Literature DB >> 8937292

Racial variation in dosage requirements of tacrolimus.

P A Andrews, M Sen, R W Chang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8937292     DOI： 10.1016/S0140-6736(04)70087-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  A higher dose requirement of tacrolimus in active Crohn's disease may be related to a high intestinal P-glycoprotein content.

Authors:  Alan L Buchman; Mary F Paine; Anita Wallin; Shana S Ludington
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

2.  Ethnic disparities in liver transplantation.

Authors:  Nyingi Kemmer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-05

3.  Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: A comparison of four ancestry groups.

Authors:  Moataz E Mohamed; David P Schladt; Weihua Guan; Baolin Wu; Jessica van Setten; Brendan J Keating; David Iklé; Rory P Remmel; Casey R Dorr; Roslyn B Mannon; Arthur J Matas; Ajay K Israni; William S Oetting; Pamala A Jacobson
Journal:  Am J Transplant       Date:  2019-05-13       Impact factor: 8.086

Review 4.  Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation.

Authors:  C M Spencer; K L Goa; J C Gillis
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 5.  The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.

Authors:  Dennis A Hesselink; Rachida Bouamar; Laure Elens; Ron H N van Schaik; Teun van Gelder
Journal:  Clin Pharmacokinet       Date:  2014-02       Impact factor: 6.447

6.  Association Between Neighborhood-level Socioeconomic Deprivation and the Medication Level Variability Index for Children Following Liver Transplantation.

Authors:  Sharad I Wadhwani; John C Bucuvalas; Cole Brokamp; Ravinder Anand; Ashutosh Gupta; Stuart Taylor; Eyal Shemesh; Andrew F Beck
Journal:  Transplantation       Date:  2020-11       Impact factor: 5.385

7.  Significant pharmacokinetic differences of berberine are attributable to variations in gut microbiota between Africans and Chinese.

Authors:  Raphael N Alolga; Yong Fan; Zhuo Chen; Li-Wei Liu; Yi-Jing Zhao; Jin Li; Yan Chen; Mao-De Lai; Ping Li; Lian-Wen Qi
Journal:  Sci Rep       Date:  2016-06-10       Impact factor: 4.379

8.  Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.

Authors:  K Sanghavi; R C Brundage; M B Miller; D P Schladt; A K Israni; W Guan; W S Oetting; R B Mannon; R P Remmel; A J Matas; P A Jacobson
Journal:  Pharmacogenomics J       Date:  2015-12-15       Impact factor: 3.550

9.  Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients.

Authors:  Lihui Qu; Yingying Lu; Meike Ying; Bingjue Li; Chunhua Weng; Zhoutao Xie; Ludan Liang; Chuan Lin; Xian Yang; Shi Feng; Yucheng Wang; Xiujin Shen; Qin Zhou; Ying Chen; Zhimin Chen; Jianyong Wu; Weiqiang Lin; Yi Shen; Jing Qin; Hang Xu; Feng Xu; Junwen Wang; Jianghua Chen; Hong Jiang; Hongfeng Huang
Journal:  Oncotarget       Date:  2017-05-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.